ATLANTA, GA, SeedtoB Capital, has invested in Epinoma, an early-stage biotechnology company developing a novel platform for protein engineering.

Epinoma leverages the detection of epigenetic signals in the body for early-stage cancer detection and minimal residual disease (MRD) monitoring. Its proprietary technology searches for methylation patterns in patients' blood, offering increased accuracy and sensitivity compared to widely used practices.